Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 4
1952 3
1953 6
1954 4
1955 3
1956 5
1957 6
1958 11
1959 7
1960 7
1961 5
1962 17
1963 29
1964 92
1965 51
1966 42
1967 66
1968 84
1969 75
1970 96
1971 110
1972 126
1973 137
1974 160
1975 172
1976 149
1977 139
1978 145
1979 166
1980 162
1981 167
1982 182
1983 185
1984 204
1985 196
1986 214
1987 245
1988 225
1989 240
1990 260
1991 274
1992 301
1993 358
1994 359
1995 394
1996 429
1997 454
1998 540
1999 544
2000 597
2001 607
2002 590
2003 804
2004 831
2005 850
2006 829
2007 925
2008 981
2009 1046
2010 1216
2011 1293
2012 1529
2013 1739
2014 1774
2015 1788
2016 1827
2017 1700
2018 1604
2019 1510
2020 1540
2021 1509
2022 1295
2023 1077
2024 1009
2025 848

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35,924 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.
Holford NH. Holford NH. Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005. Clin Pharmacokinet. 1986. PMID: 3542339 Review.
A pharmacodynamic model for the effect of warfarin on the synthesis of clotting factors (prothrombin complex). Prothrombin complex synthesis is inhibited 50% at a warfarin concentration of about 1.5 mg/L. Warfarin concentrations associated with therapeutic an …
A pharmacodynamic model for the effect of warfarin on the synthesis of clotting factors (prothrombin complex). Prothrombin complex sy …
Systematic overview of warfarin and its drug and food interactions.
Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. Holbrook AM, et al. Arch Intern Med. 2005 May 23;165(10):1095-106. doi: 10.1001/archinte.165.10.1095. Arch Intern Med. 2005. PMID: 15911722 Review.
Of all reports, 72% described a potentiation of warfarin's effect and 84% were of poor quality, 86% of which were single case reports. The 31 incidents of clinically significant bleeding were all single case reports. ...More systematic study of warfarin drug …
Of all reports, 72% described a potentiation of warfarin's effect and 84% were of poor quality, 86% of which were single case …
Warfarin pharmacogenomics.
Cavallari LH, Limdi NA. Cavallari LH, et al. Curr Opin Mol Ther. 2009 Jun;11(3):243-51. Curr Opin Mol Ther. 2009. PMID: 19479657 Review.
Warfarin therapy is complicated by a narrow therapeutic index and substantial interpatient variability in dose response. ...The results of ongoing or future multicenter clinical trials are expected to clarify the role of pharmacogenomics in the management of warfarin …
Warfarin therapy is complicated by a narrow therapeutic index and substantial interpatient variability in dose response. ...The resul …
Warfarin therapy. 2.
Deykin D. Deykin D. N Engl J Med. 1970 Oct 8;283(15):801-3. doi: 10.1056/NEJM197010082831508. N Engl J Med. 1970. PMID: 4917271 Review. No abstract available.
Warfarin-rifampicin interaction.
Fox P. Fox P. Med J Aust. 1982 Jan 23;1(2):60. doi: 10.5694/j.1326-5377.1982.tb132151.x. Med J Aust. 1982. PMID: 7070329 No abstract available.
Griseofulvin-warfarin antagonism.
Cullen SI, Catalano PM. Cullen SI, et al. JAMA. 1967 Feb 20;199(8):582-3. JAMA. 1967. PMID: 6071326 No abstract available.
Warfarin.
Benya TJ, Adler DS, Bates TR. Benya TJ, et al. J Am Pharm Assoc. 1976 May;16(5):271-4. J Am Pharm Assoc. 1976. PMID: 1270740 No abstract available.
Do all histamine2-antagonists cause a warfarin drug interaction?
Hussey EK, Dukes GE. Hussey EK, et al. DICP. 1989 Sep;23(9):675-9. doi: 10.1177/106002808902300911. DICP. 1989. PMID: 2572090 Review.
Ranitidine has been implicated in both increasing and decreasing warfarin's hypoprothrombinemic-effect (noted in the warfarin package insert), despite the majority of investigations demonstrating no warfarin clearance changes. Careful examination of th …
Ranitidine has been implicated in both increasing and decreasing warfarin's hypoprothrombinemic-effect (noted in the warfar …
Initiating warfarin therapy.
Dager WE. Dager WE. Ann Pharmacother. 2003 Jun;37(6):905-8. doi: 10.1345/aph.1D038. Ann Pharmacother. 2003. PMID: 12773083 No abstract available.
Pharmacogenomics and warfarin.
Anderson DC Jr. Anderson DC Jr. Am J Health Syst Pharm. 2009 Jan 15;66(2):121. doi: 10.2146/ajhp080635. Am J Health Syst Pharm. 2009. PMID: 19139475 No abstract available.
35,924 results
You have reached the last available page of results. Please see the User Guide for more information.